Risk factor
Limited trading liquidity
Profitability factor
Very strong margins and returns
About
Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, was founded in 1982 and is based in Bangkok, Thailand. This diversified healthcare enterprise is primarily involved in the production, promotion, and sale of an extensive array of health-related products, encompassing dietary supplements, over-the-counter (OTC) and prescription pharmaceuticals, herbal remedies, vitamins, and fast-moving consumer goods. The company organizes its activities across three main divisions: Brands, Distribution, and Original Equipment Manufacture (OEM). Its vast product portfolio includes a wide selection of complementary medicines designed for various needs, such as bone and joint support, children's health, diabetes and heart care, herbal solutions, liver and digestive well-being, skin health, weight management, overall vitality, specific men's and women's health products, and sports nutrition. Additionally, the pharmaceutical segment provides OTC solutions for gastrointestinal issues and pain, alongside a comprehensive range of prescription drugs targeting therapeutic areas like iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain management, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its core product lines, Mega Lifesciences offers logistical and marketing services for goods manufactured by other companies. It also operates wellness centers and engages in software design, development, and related service provisions. The company maintains a strong global footprint, with operations spanning the Asia Pacific, the Middle East, Africa, and the Commonwealth of Independent States regions.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E